home / stock / mkeaf / mkeaf news
Mauna Kea Technologies (OTCPK:MKEAF) (OTCPK:MKEAY) said it received a U.S. FDA 510(k) clearance for the use of Cellvizio 100 Series platform with a molecular imaging agent, the first of its kind, for real-time in vivo visualization during endoscopic, laparoscopic, and needle-based procedures....
Mauna Kea Technologies ADR (MKEAY): Q2 Revenue of €1.7M (+183.3% Y/Y)Assuming the global capital equipment recovery continues, the Company continues to expect to increase sales in the range of 25% to 30% year-over-year for the twelve months ending December 31, 2021 vs. consensus g...
Mauna Kea Technologies ( OTCPK:MKEAF ) signed the original loan agreement in July 2019 and included an initial tranche of €11.5M. More news on: Mauna Kea Technologies SA, , Read more ...
Mauna Kea Technologies ( OTCPK:MKEAF ): Q2 Revenue of €2.22M (+32.9% Y/Y) Press Release More news on: Mauna Kea Technologies SA, Earnings news and commentary, Consumer stocks news, ,